UPMC Physician Resources

Take the CME Evaluation

2016 Pitt-Munich International Lung Conference: Part 1

Drs. Anuradha Ray and Jay Kolls each present from the 2016 Pitt-Munich International Lung Conference. Dr. Ray discusses Immune Tolerance in Maintenance of Lung Heath and Loss in Disease and Dr. Kolls discusses Type17 Cells and Defense against Lung Pathogens.

Educational objectives:

Upon completion of this activity, participants should be able to:

  • Recognize that immune mechanisms, both positive and negative, impact respiratory health.
  • Recognize the role of mitochondrial H2O2 as a negative regulator of inflammation in the face of constant provocation of the respiratory tract by environmental agents.
  • Identify a role of the cytokine interferon gamma (IFN-g) in severe asthma.
  • Review primary genetic mutations that confer increases risk of fungal pneumonia. 
  • Review mechanisms by which primary genetic mutations that confer increases risk of fungal pneumonia
  • Review how IL-22 has in vivo anti-fungal activity in pre-clinical models of fungal pneumonia

Reading Resources:

  1. Khare, A., Raundhal, M., Chakraborty, K., Das, S., Corey, C., Kamga, CK, Quesnelle, K., St. Croix, C., Watkins, S.C., Morse, C., Oriss, T.B., Huff, R., Hannum, R., Ray, P, Shiva, S., Ray, A. (2016) Mitochondrial H2O2 in lung antigen-presenting cells blocks NF-?B activation to block unwarranted immune activation. Cell Reports 15:1700-1714.
  2. Raundhal, M., Morse, M., Khare, A., Oriss, T.B., Milosevic, J., Trudeau, J., Huff, R., Pilewski, J., Holguin, F., Kolls, J. Wenzel, S.E., Ray, P. ¶,, Ray, A. ¶, (2015) High IFN-? and Low  SLPI Mark Severe Asthma In Humans and Mice. J. Clin. Invest. 125:3037-3050. PMID: 26121748. ¶,-co-senior authors.
  3. Ray, A., Raundhal, M., Oriss, T.B., Ray, P., Ray, A. (2016) Current concepts of severe asthma. J. Clin. Invest. 126:2394-2403.
  4. Arian Laurence, John J O'Shea & Wendy T Watford,  Nature Medicine 14, 247 - 249 (2008)
  5. CI Insight. 2016 Jul 21;1(11). pii: e87168.


Dr. Ray has reported no relevant relationships with proprietary entities producing health care goods or services

Dr. Kolls has financial interests with the following proprietary entity or entities producing health care goods or services as indicated below:

  • Grant/Research Support: Grants from NHLBI and NIAID
  • Consultant: Boehringer - Ingelheim, Vitae

All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above.  No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement:

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.075) continuing education units (CEU) which are equivalent to .75 contact hour.

For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.edu and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.

Release Date: 1/31/2017 | Last Modified On: 1/31/2017 | Expires: 1/31/2018


Anuradha Ray, PhD

Anuradha Ray, PhD Professor of Medicine and Immunology
View Full Profile

Jay K. Kolls, MD

Jay K. Kolls, MD Director, Richard King Mellon Foundation Institute for Pediatric Research Professor of Pediatrics and Immunology, University of Pittsburgh School of Medicine Vice Chair for Translational Research Interim NIH T32 Program Director, Division of Pediatric Rheumatology
View Full Profile